RHY — Rhythm Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$24.15m
- AU$22.92m
- AU$0.23m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.43 | 0.841 | 1.18 | 2.45 | 3.32 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.94 | -2.74 | -5.4 | -6.5 | -6.96 |
Capital Expenditures | -0.11 | -0.046 | -0.068 | -0.027 | -0.099 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.11 | -0.046 | -0.068 | -0.027 | -0.099 |
Financing Cash Flow Items | 0 | — | -0.225 | -0.468 | -0.024 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | -0.142 | 5.9 | 11.8 | 3.63 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.05 | -2.93 | 0.43 | 5.32 | -3.43 |